These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20023240)

  • 41. Cheminformatics-based selection and synergism of herbal extracts with anticancer agents on drug resistance tumor cells-ACHN and A2780/cp cell lines.
    Ghavami G; Sardari S; Ali Shokrgozar M
    Comput Biol Med; 2011 Aug; 41(8):665-74. PubMed ID: 21752359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanocapsules for the co-delivery of selol and doxorubicin to breast adenocarcinoma 4T1 cells in vitro.
    Ganassin R; Merker C; Rodrigues MC; Guimarães NF; Sodré CSC; Ferreira QDS; da Silva SW; Ombredane AS; Joanitti GA; Py-Daniel KR; Zhang J; Jiang CS; de Morais PC; Mosiniewicz-Szablewska E; Suchocki P; Longo JPF; Meijer J; Estrela-Lopis I; de Azevedo RB; Muehlmann LA
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2002-2012. PubMed ID: 29179603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study on drug sensitivity of the TA3/Ha and TA3/St tumor sublines.
    Gál F; Sugár J; Susan SR
    Oncology; 1979; 36(2):84-8. PubMed ID: 460789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic markers of MG-63 osteosarcoma cell line response to doxorubicin and methotrexate treatment: comparison to cisplatin.
    Lamego I; Duarte IF; Marques MP; Gil AM
    J Proteome Res; 2014 Dec; 13(12):6033-45. PubMed ID: 25382592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrochemical monitoring of rat mammary adenocarcinoma cells: an in vitro assay for anticancer drug selection.
    Adlam DJ; Dabbous MK; Woolley DE
    Assay Drug Dev Technol; 2008 Dec; 6(6):795-802. PubMed ID: 19231941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Host-defense peptide mimicry for novel antitumor agents.
    Held-Kuznetsov V; Rotem S; Assaraf YG; Mor A
    FASEB J; 2009 Dec; 23(12):4299-307. PubMed ID: 19706728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycosylated nordihydroguaiaretic acids as anti-cancer agents.
    Hwu JR; Hsu CI; Hsu MH; Liang YC; Huang RC; Lee YC
    Bioorg Med Chem Lett; 2011 Jan; 21(1):380-2. PubMed ID: 21123067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemosensitizing Properties of β-Caryophyllene and β-Caryophyllene Oxide in Combination with Doxorubicin in Human Cancer Cells.
    DI Giacomo S; DI Sotto A; Mazzanti G; Wink M
    Anticancer Res; 2017 Mar; 37(3):1191-1196. PubMed ID: 28314281
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro efficacy of chemotherapeutics as determined by 50% inhibitory concentrations in cell cultures of mammary gland tumors obtained from dogs.
    Simon D; Knebel JW; Baumgartner W; Aufderheide M; Meyer-Lindenberg A; Nolte I
    Am J Vet Res; 2001 Nov; 62(11):1825-30. PubMed ID: 11703031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer.
    Rottenberg S; Nygren AO; Pajic M; van Leeuwen FW; van der Heijden I; van de Wetering K; Liu X; de Visser KE; Gilhuijs KG; van Tellingen O; Schouten JP; Jonkers J; Borst P
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12117-22. PubMed ID: 17626183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity and resistance towards isoliquiritigenin, doxorubicin and methotrexate in T cell acute lymphoblastic leukaemia cell lines by pharmacogenomics.
    Youns M; Fu YJ; Zu YG; Kramer A; Konkimalla VB; Radlwimmer B; Sültmann H; Efferth T
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Sep; 382(3):221-34. PubMed ID: 20668838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression.
    Catanzaro D; Gabbia D; Cocetta V; Biagi M; Ragazzi E; Montopoli M; Carrara M
    Fitoterapia; 2018 Jan; 124():42-48. PubMed ID: 29031537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitumour activity of miltefosine alone and after combination with platinum complexes on MXT mouse mammary carcinoma models.
    Spruss T; Bernhardt G; Schönenberger H; Engel J
    J Cancer Res Clin Oncol; 1993; 119(3):142-9. PubMed ID: 8418086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of nordihydroguaiaretic acid derivatives and their bioactivities on S. pombe and K562 cell lines.
    Li X; Jiang JH; Chen Q; Xiao SX; Li CH; Gu HW; Zhang H; Hu JL; Yao FH; Li QG
    Eur J Med Chem; 2013 Apr; 62():605-13. PubMed ID: 23434529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of the antimetastatic drug Batimastat on tumor growth and PO2 measured by EPR oximetry in a murine mammary adenocarcinoma.
    James PE; O'Hara JA; Grinberg S; Panz T; Swartz HM
    Adv Exp Med Biol; 1999; 471():487-96. PubMed ID: 10659182
    [No Abstract]   [Full Text] [Related]  

  • 56. Telomere dynamics determine episodes of anticancer drug resistance in rat hepatoma cells.
    Deschatrette J; Ng KH; Gouthière L; Maigné J; Guerroui S; Wolfrom C
    Anticancer Drugs; 2004 Aug; 15(7):671-8. PubMed ID: 15269598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.
    Meyers RO; Lambert JD; Hajicek N; Pourpak A; Kalaitzis JA; Dorr RT
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4752-5. PubMed ID: 19615898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in tissue fatty acid composition in murine malignancy and following anticancer therapy.
    Yazici Z; Tavares IA; Stamford IF; Bishai PM; Bennett A
    Br J Cancer; 1992 Feb; 65(2):163-70. PubMed ID: 1739611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of adenocarcinoma TA3 ascites tumor growth by rifamycin derivatives.
    Hughes AM; Tenforde TS; Calvin M; Bissell MJ; Tischler AN; Bennett EL
    Oncology; 1978; 35(2):76-82. PubMed ID: 652266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differing electrical surface charge and transplantation properties of genetically variant sublines of the TA3 murine adenocarcinoma tumor.
    Tenforde TS; Adesida PO; Kelly LS; Todd PW
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):277-82. PubMed ID: 6681773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.